-
1
-
-
0033964872
-
Lipodystrophies
-
Garg A. Lipodystrophies. Am JMed 2000; 108:143-152
-
(2000)
Am JMed
, vol.108
, pp. 143-152
-
-
Garg, A.1
-
2
-
-
1542510700
-
Acquired and inherited lipodystrophies
-
Garg A. Acquired and inherited lipodystrophies. N Engl J Med 2004;350: 1220-1234
-
(2004)
N Engl J Med
, vol.350
, pp. 1220-1234
-
-
Garg, A.1
-
3
-
-
67349228443
-
Lipodystrophies: Disorders of adipose tissue biology
-
Garg A, Agarwal AK. Lipodystrophies: disorders of adipose tissue biology. Biochim Biophys Acta 2009;1791:507-513
-
(2009)
Biochim Biophys Acta
, vol.1791
, pp. 507-513
-
-
Garg, A.1
Agarwal, A.K.2
-
4
-
-
80655145234
-
Lipodystrophies: Genetic and acquired body fat disorders
-
Garg A. Lipodystrophies: genetic and acquired body fat disorders. J Clin Endocrinol Metab 2011;96:3313-3325
-
(2011)
J Clin Endocrinol Metab
, vol.96
, pp. 3313-3325
-
-
Garg, A.1
-
5
-
-
77953939677
-
Clinical classification and treatment of congenital and acquired lipodystrophy
-
Chan JL, Oral EA. Clinical classification and treatment of congenital and acquired lipodystrophy. Endocr Pract 2010;16:310-323
-
(2010)
Endocr Pract.
, vol.16
, pp. 310-323
-
-
Chan, J.L.1
Oral, E.A.2
-
6
-
-
10344228731
-
Dysfunctional fat cells, lipotoxicity and type 2 diabetes
-
Oct
-
DeFronzo RA. Dysfunctional fat cells, lipotoxicity and type 2 diabetes. Int J Clin Pract Suppl 2004;Oct:9-21
-
(2004)
Int J Clin Pract Suppl
, pp. 9-21
-
-
Defronzo, R.A.1
-
7
-
-
79952451443
-
Obesity, insulin resistance and free fatty acids
-
Boden G. Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes 2011;18:139-143
-
(2011)
Curr Opin Endocrinol Diabetes Obes
, vol.18
, pp. 139-143
-
-
Boden, G.1
-
8
-
-
46249093117
-
Overproduction of very lowdensity lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome
-
Adiels M, Olofsson SO, Taskinen MR, Borén J. Overproduction of very lowdensity lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008;28: 1225-1236
-
(2008)
Arterioscler Thromb Vasc Biol.
, vol.28
, pp. 1225-1236
-
-
Adiels, M.1
Olofsson, S.O.2
Taskinen, M.R.3
Borén, J.4
-
9
-
-
0032775947
-
Relation of triglyceride stores in skeletal muscle cells to central obesity and insulin sensitivity in European and South Asian men
-
Forouhi NG, Jenkinson G, Thomas EL, et al. Relation of triglyceride stores in skeletal muscle cells to central obesity and insulin sensitivity in European and South Asian men. Diabetologia 1999;42:932-935
-
(1999)
Diabetologia
, vol.42
, pp. 932-935
-
-
Forouhi, N.G.1
Jenkinson, G.2
Thomas, E.L.3
-
10
-
-
0036092239
-
Banting lecture 2001: Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes
-
McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002; 51:7-18
-
(2002)
Diabetes
, vol.51
, pp. 7-18
-
-
McGarry, J.D.1
-
11
-
-
77952563455
-
Liver fat in the pathogenesis of insulin resistance and type 2 diabetes
-
Yki-Järvinen H. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes. Dig Dis 2010;28:203-209
-
(2010)
Dig Dis
, vol.28
, pp. 203-209
-
-
Yki-Järvinen, H.1
-
12
-
-
33644967119
-
The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity
-
Dyck DJ, Heigenhauser GJ, Bruce CR. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiol (Oxf) 2006;186: 5-16
-
(2006)
Acta Physiol (Oxf)
, vol.186
, pp. 5-16
-
-
Dyck, D.J.1
Heigenhauser, G.J.2
Bruce, C.R.3
-
13
-
-
0034708580
-
Mechanism of insulin resistance in A-ZIP/F-1 fatless mice
-
Kim JK, Gavrilova O, Chen Y, Reitman ML, Shulman GI. Mechanism of insulin resistance in A-ZIP/F-1 fatless mice. J Biol Chem 2000;275:8456-8460
-
(2000)
J Biol Chem.
, vol.275
, pp. 8456-8460
-
-
Kim, J.K.1
Gavrilova, O.2
Chen, Y.3
Reitman, M.L.4
Shulman, G.I.5
-
14
-
-
80054822747
-
Human 1-acylglycerol-3-phosphate O-acyltransferase isoforms 1 and 2: Biochemical characterization and inability to rescue hepatic steatosis in Agpat2(-/-) gene lipodystrophic mice
-
Agarwal AK, Sukumaran S, Cortés VA, et al. Human 1-acylglycerol-3-phosphate O-acyltransferase isoforms 1 and 2: biochemical characterization and inability to rescue hepatic steatosis in Agpat2(-/-) gene lipodystrophic mice. J Biol Chem 2011;286:37676-37691
-
(2011)
J Biol Chem.
, vol.286
, pp. 37676-37691
-
-
Agarwal, A.K.1
Sukumaran, S.2
Cortés, V.A.3
-
15
-
-
0036381998
-
Adipose tissue as a buffer for daily lipid flux
-
Frayn KN. Adipose tissue as a buffer for daily lipid flux. Diabetologia 2002;45: 1201-1210
-
(2002)
Diabetologia
, vol.45
, pp. 1201-1210
-
-
Frayn, K.N.1
-
16
-
-
66849093697
-
Muscle inflammatory response and insulin resistance: Synergistic interaction between macrophages and fatty acids leads to impaired insulin action
-
Varma V, Yao-Borengasser A, Rasouli N, et al. Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action. Am J Physiol Endocrinol Metab 2009;296: E1300-E1310
-
(2009)
Am J Physiol Endocrinol Metab
, vol.296
, pp. 1300-1310
-
-
Varma, V.1
Yao-Borengasser, A.2
Rasouli, N.3
-
17
-
-
84863115343
-
Role and function of macrophages in the metabolic syndrome
-
Bhargava P, Lee CH. Role and function of macrophages in the metabolic syndrome. Biochem J 2012;442:253-262
-
(2012)
Biochem J
, vol.442
, pp. 253-262
-
-
Bhargava, P.1
Lee, C.H.2
-
18
-
-
76249097775
-
Inflammation and adipose tissue macrophages in lipodystrophic mice
-
Herrero L, Shapiro H, Nayer A, Lee J, Shoelson SE. Inflammation and adipose tissue macrophages in lipodystrophic mice. Proc Natl Acad Sci U S A 2010;107: 240-245
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 240-245
-
-
Herrero, L.1
Shapiro, H.2
Nayer, A.3
Lee, J.4
Shoelson, S.E.5
-
19
-
-
0021990787
-
KoltermanOG the effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus
-
Garvey WT, Olefsky JM, Griffin J, Hamman RF, KoltermanOG. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes 1985;34:222-234
-
(1985)
Diabetes
, vol.34
, pp. 222-234
-
-
Garvey, W.T.1
Olefsky, J.M.2
Griffin, J.3
Hamman, R.F.4
-
20
-
-
0020774420
-
Estimation and kinetic analysis of insulinindependent glucose uptake in human subjects
-
Gottesman I, Mandarino L, Gerich J. Estimation and kinetic analysis of insulinindependent glucose uptake in human subjects. Am J Physiol 1983;244:E632-E635
-
(1983)
Am J Physiol.
, vol.244
, pp. 632-635
-
-
Gottesman, I.1
Mandarino, L.2
Gerich, J.3
-
21
-
-
77956978001
-
Assessment of non-insulin-mediated glucose uptake: Association with body fat and glycemic status
-
Jumpertz R, Thearle MS, Bunt JC, Krakoff J. Assessment of non-insulin-mediated glucose uptake: association with body fat and glycemic status. Metabolism 2010;59: 1396-1401
-
(2010)
Metabolism
, vol.59
, pp. 1396-1401
-
-
Jumpertz, R.1
Thearle, M.S.2
Bunt, J.C.3
Krakoff, J.4
-
22
-
-
0041668112
-
Köbberling type of familial partial lipodystrophy: An underrecognized syndrome
-
Herbst KL, Tannock LR, Deeb SS, Purnell JQ, Brunzell JD, Chait A. Köbberling type of familial partial lipodystrophy: an underrecognized syndrome. Diabetes Care 2003;26:1819-1824
-
(2003)
Diabetes Care
, vol.26
, pp. 1819-1824
-
-
Herbst, K.L.1
Tannock, L.R.2
Deeb, S.S.3
Purnell, J.Q.4
Brunzell, J.D.5
Chait, A.6
-
23
-
-
36849071396
-
New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome
-
Decaudain A, Vantyghem MC, Guerci B, et al. New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome. J Clin Endocrinol Metab 2007;92:4835-4844
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 4835-4844
-
-
Decaudain, A.1
Vantyghem, M.C.2
Guerci, B.3
-
24
-
-
79959730637
-
Characterisation of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPARg mutation (Y151C)
-
Visser ME, Kropman E, Kranendonk ME, et al. Characterisation of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPARg mutation (Y151C). Diabetologia 2011;54: 1639-1644
-
(2011)
Diabetologia
, vol.54
, pp. 1639-1644
-
-
Visser, M.E.1
Kropman, E.2
Kranendonk, M.E.3
-
25
-
-
68449089522
-
Inherited lipodystrophies and hypertriglyceridemia
-
Simha V, Garg A. Inherited lipodystrophies and hypertriglyceridemia. Curr Opin Lipidol 2009;20:300-308
-
(2009)
Curr Opin Lipidol
, vol.20
, pp. 300-308
-
-
Simha, V.1
Garg, A.2
-
26
-
-
77953954942
-
Rationale for leptinreplacement therapy for severe lipodystrophy
-
Oral EA, Chan JL. Rationale for leptinreplacement therapy for severe lipodystrophy. Endocr Pract 2010;16:324-333
-
(2010)
Endocr Pract.
, vol.16
, pp. 324-333
-
-
Oral, E.A.1
Chan, J.L.2
-
27
-
-
72449185147
-
Efficacy of leptin therapy in the different forms of human lipodystrophy
-
Chong AY, Lupsa BC, Cochran EK, Gorden P. Efficacy of leptin therapy in the different forms of human lipodystrophy. Diabetologia 2010;53:27-35
-
(2010)
Diabetologia
, vol.53
, pp. 27-35
-
-
Chong, A.Y.1
Lupsa, B.C.2
Cochran, E.K.3
Gorden, P.4
-
28
-
-
84858027751
-
Comparison of efficacy and safety of leptin replacement therapy in moderately and severely hypoleptinemic patientswith familial partial lipodystrophy of the Dunnigan variety
-
Simha V, SubramanyamL, Szczepaniak L, et al. Comparison of efficacy and safety of leptin replacement therapy in moderately and severely hypoleptinemic patientswith familial partial lipodystrophy of the Dunnigan variety. J Clin Endocrinol Metab 2012;97:785-792
-
(2012)
J Clin Endocrinol Metab
, vol.97
, pp. 785-792
-
-
Simha, V.1
Subramanyam, L.2
Szczepaniak, L.3
|